Cargando…
Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
BACKGROUND: Glioma is the most common primary brain tumor, representing approximately 80.8% of malignant tumors. Necroptosis triggers and enhances antitumor immunity and is expected to be a new target for tumor immunotherapy. The effectiveness of necroptosis-related lncRNAs as potential therapeutic...
Autores principales: | Jiang, Fan, Zhan, Zheng, Yang, Yanbo, Liu, Guangjie, Liu, Song, Gu, Jingyu, Chen, Zhouqing, Wang, Zhong, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440826/ https://www.ncbi.nlm.nih.gov/pubmed/36065303 http://dx.doi.org/10.1155/2022/5681206 |
Ejemplares similares
-
A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma
por: Wu, Zhikang, et al.
Publicado: (2022) -
Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022) -
Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer
por: Liu, Yang, et al.
Publicado: (2022) -
A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022) -
Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)